NCT06734520View on ClinicalTrials.gov

Clinical Study of Super Transplantation in the Treatment of Severe β-thalassemia

NARecruitingINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

October 1, 2024

Primary Completion Date

July 1, 2029

Study Completion Date

July 1, 2029

Conditions
Thalassemia Majors (Beta-Thalassemia Major)Haplo-identical Donors
Interventions
DRUG

super-transplantation in 3 severe β -thalassemia pediatric patients.

Haplo-identical donors are mobilized with G-CSF and PBMCs that contain CD34+ stem cells and CD3+ lymphocytes will be extracted by blood cell separators. Then the patients will be infused with the PBMC

Trial Locations (2)

51000

ACTIVE_NOT_RECRUITING

Guangzhou Women and Children's Medical Center Affiliated to Guangzhou Medical University, Guangzhou

Unknown

RECRUITING

Guangzhou Women and Children's Medical Center Affiliated to Guangzhou Medical University, Guangzhou

All Listed Sponsors
lead

Guangzhou Women and Children's Medical Center

OTHER